Submissions for variant NM_000053.4(ATP7B):c.3990_3993del (p.Tyr1331fs)

Minimum review status:		Collection method:
Minimum conflict level: Report conflict between different conditions
		ClinVar version:

Total submissions: 4

Download table as spreadsheet

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories	RCV000755841	SCV000883443	pathogenic	not provided	2017-05-10	criteria provided, single submitter	clinical testing	To our knowledge, the ATP7B c.3990_3993delTTAT; p.Tyr1331fs variant has not been previously reported in the literature, gene-specific variant databases, or general population databases (Exome Variant Server, Genome Aggregation Database). This variant creates a frameshift and is predicted to result in a truncated protein or absent transcript, and is considered pathogenic.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp	RCV001175559	SCV001339185	likely pathogenic	Wilson disease	2020-03-26	criteria provided, single submitter	clinical testing	Variant summary: ATP7B c.3990_3993delTTAT (p.Tyr1331ThrfsX61) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 249548 control chromosomes (gnomAD). c.3990_3993delTTAT has been reported in the literature in individuals affected with Wilson Disease (Jung_2017). These data do not allow any conclusion about variant significance. At least one publication reports experimental evidence evaluating an impact on protein function, however, does not allow convincing conclusions about the variant effect (Jung_2017). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic.
Genome-Nilou Lab	RCV001175559	SCV001977219	pathogenic	Wilson disease	2021-08-10	criteria provided, single submitter	clinical testing
Baylor Genetics	RCV001175559	SCV004216455	pathogenic	Wilson disease	2023-03-15	criteria provided, single submitter	clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.